Journal
EUROPEAN JOURNAL OF NEUROLOGY
Volume 14, Issue 4, Pages 418-423Publisher
WILEY
DOI: 10.1111/j.1468-1331.2007.01686.x
Keywords
antiretroviral therapy; human immunodeficiency virus; progressive multifocal leucoencephalopathy; survival
Categories
Ask authors/readers for more resources
We performed a retrospective review of cases of human immunodeficiency virus-associated progressive multifocal leucoencephalopathy in four hospitals (three in Australia and one in Hong Kong) between 1987 and 2003 in order to describe the local experience with this disease and to evaluate parameters impacting upon survival. Eighty-seven cases were identified and demographic details, baseline parameters and treatment methods and response were described. Survival was substantially increased in the post-highly active antiretroviral therapy (HAART) era with a median survival increase from 14 to 64 weeks. On multivariate analysis, variables associated with prolonged survival included a CD4 count of > 100 cells/mu l at diagnosis and the use of HAART post-diagnosis, with no significant additional advantage from the use of neuroactive antiretrovirals.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available